@HealthReadiness
info@healthsystemreadiness.com
  • All
  • Events
  • News
  • Opinion
  • Radioligand Therapy
    • News
    Leading experts join HPP and Avalere to examine readiness for radioligand therapy in the US

    Leading experts join HPP and Avalere to examine readiness for radioligand therapy in the US

    The Health Policy Partnership (HPP) and Avalere Health recently held a webinar on the use of radioligand therapy and readiness for its future integration in the US.
    Read More
    News
    HPP launches policy brief at an event coinciding with ESMO 2021

    HPP launches policy brief at an event coinciding with ESMO 2021

    HPP was thrilled to launch its new policy brief 'Fostering system readiness in cancer care' on 21 September 2021, at an event coinciding with ESMO 2021.
    Read More
    News
    Achieving system readiness for radioligand therapy in the UK: the event as it happened

    Achieving system readiness for radioligand therapy in the UK: the event as it happened

    On 9 September, The Health Policy Partnership (HPP) was pleased to host a webinar to launch the UK situation analysis report and policy action blueprint.
    Read More
    News
    Radioligand Therapy Readiness Assessment Framework launched at event with esteemed speakers

    Radioligand Therapy Readiness Assessment Framework launched at event with esteemed speakers

    On 9 June 2021, the new Radioligand Therapy Readiness Assessment Framework was launched at an event with a panel of international and multidisciplinary experts.
    Read More
    News
    New poster on radioligand therapy readiness published at virtual ESMO congress

    New poster on radioligand therapy readiness published at virtual ESMO congress

    The Health Policy Partnership and Professor Ken Herrmann have published a poster at the virtual European Society for Medical Oncology (ESMO) congress 2020.
    Read More
    News
    Poster published at ECRD focuses on radioligand therapy in neuroendocrine neoplasms

    Poster published at ECRD focuses on radioligand therapy in neuroendocrine neoplasms

    The Health Policy Partnership has published a poster at the 10th European Conference on Rare Diseases & Orphan Products (ECRD).
    Read More
    News
    New poster published at ENETS virtual conference

    New poster published at ENETS virtual conference

    The Health Policy Partnership presented a poster on radioligand therapy at the European Neuroendocrine Tumor Society (ENETS) conference.
    Read More
    News
    Radioligand therapy recommendations form part of submission to Europe’s Beating Cancer Plan

    Radioligand therapy recommendations form part of submission to Europe’s Beating Cancer Plan

    Recommendations from the radioligand therapy policy report have formed the basis of a submission to Europe’s Beating Cancer Plan, addressing the burden of cancer in the EU.
    Read More
    News
    Policy report on radioligand therapy launched at European Parliament

    Policy report on radioligand therapy launched at European Parliament

    On 22 January 2020, The Health Policy Partnership and an expert-led steering committee launched a policy report on radioligand therapy at the European Parliament.
    Read More